Skip to search formSkip to main contentSkip to account menu

FCE 23884

Known as: 2,6-Piperazinedione, 4-(((8beta)-9,10-didehydro-6-methylergolin-8-yl)methyl)-, FCE-23884 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ergolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
The ergoline derivative FCE 23884 acts as a dopamine D1 agonist in untreated parkinsonian animals and as a D2 antagonist in… 
1993
1993
Determination of FCE 23884, a new ergolene derivative, and its possible metabolite, the 6-nor-derivative in plasma by high-performance liquid chromatography with fluorescence detection.
1992
1992
A new dopamine agonist in dopamine deprived systems: FCE 23884
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)